Creative Medical Technology Holdings Inc (CELZ)

Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	0.00	-
Cost Of Revenue	-	-	-	0.00	-
Gross Profit	-	-	-	0.00	-
	74.50%2.73	1.56	1.46	1.95	1.27
Selling, General, and Administrative	2.55%1.11	1.08	0.89	1.37	0.78
Research and Development	248.80%1.60	0.46	0.54	0.55	0.47
Operating Income/Loss	74.50%-2.73	-1.56	-1.46	-1.95	-1.27
Nonoperating Income/Loss	22.71%0.06	0.05	0.06	0.06	0.04
Income/Loss From Continuing Operations Before Tax	76.24%-2.66	-1.51	-1.40	-1.89	-1.24
Income Tax Expense/Benefit	-	-	-	-	-
	76.24%-2.66	-1.51	-1.40	-1.89	-1.24
Attributable To Parent	76.60%-2.67	-1.51	-1.41	-1.89	-1.24
Attributable To Noncontrolling Interest	808.82%0.01	0.00	0.00	-	-
Diluted Average Shares	79.96%6.66	3.70	3.70	-	2.58
Diluted Earnings Per Share	2.44%-0.40	-0.41	-0.38	-	-0.48